Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
276.08B | 252.71B | 226.34B | 213.00B | 204.47B | Gross Profit |
63.87B | 57.91B | 51.63B | 40.28B | 32.59B | EBIT |
29.11B | 27.22B | 23.55B | 14.25B | 8.23B | EBITDA |
58.88B | 56.87B | 55.50B | 43.00B | 36.26B | Net Income Common Stockholders |
19.83B | 18.85B | 15.67B | 9.71B | 4.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
45.47B | 44.39B | 48.69B | 44.44B | 41.34B | Total Assets |
273.71B | 246.19B | 231.81B | 220.78B | 206.52B | Total Debt |
30.18B | 20.43B | 21.87B | 25.56B | 27.75B | Net Debt |
-15.29B | -22.04B | -25.52B | -16.91B | -10.92B | Total Liabilities |
146.68B | 126.89B | 127.18B | 129.81B | 126.47B | Stockholders Equity |
125.75B | 118.12B | 103.53B | 89.96B | 79.08B |
Cash Flow | Free Cash Flow | |||
21.84B | 21.27B | 32.05B | 29.54B | 21.55B | Operating Cash Flow |
40.78B | 38.53B | 43.57B | 40.54B | 33.39B | Investing Cash Flow |
-17.93B | -18.39B | -11.84B | -13.22B | -7.26B | Financing Cash Flow |
-20.80B | -25.73B | -27.30B | -23.62B | -19.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $12.88T | 11.33 | 11.36% | 3.25% | 3.22% | -4.93% | |
76 Outperform | ¥10.24T | 16.73 | 11.94% | 3.03% | 1.71% | -4.87% | |
72 Outperform | ¥487.43B | 23.21 | 16.10% | 1.24% | 13.34% | 9.80% | |
72 Outperform | ¥26.13B | 30.56 | 1.64% | 9.52% | 15.61% | ||
72 Outperform | ¥27.37B | 31.76 | ― | 21.68% | -30.98% | ||
63 Neutral | $352.93B | 26.74 | 15.63% | 1.08% | 7.25% | -5.11% | |
59 Neutral | $13.76B | 7.70 | -1.87% | 3.86% | 2.21% | -37.55% |